Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models
Björn Corleis, Donata Hoffmann, Susanne Rauch, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17

Showing 17 citing articles:

Frameworks for transformational breakthroughs in RNA-based medicines
John R. Androsavich
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 6, pp. 421-444
Closed Access | Times Cited: 18
Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection
Baoling Ying, Tamarand L. Darling, Pritesh Desai, et al.
Nature Immunology (2024) Vol. 25, Iss. 3, pp. 537-551
Open Access | Times Cited: 12
A bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ.1.1 and XBB.1.5 infection and disease in mice and hamsters
Baoling Ying, Tamarand L. Darling, Pritesh Desai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 15
An inoculation site-retained mRNA vaccine induces robust immune responses against SARS-CoV-2 variants
Lei Huang, Fanfan Zhao, Muye He, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 479-493
Closed Access | Times Cited: 4
Omicron-specific and bivalent omicron-containing vaccine candidates elicit potent virus neutralisation in the animal model
Asghar Abdoli, Hamidreza Jamshidi, Mohammad Taqavian, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
Monika Kumari, Shih-Chieh Su, Kang-Hao Liang, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 8
Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection
Sabrina Clever, Leonard Limpinsel, Christian Meyer zu Natrup, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 417-417
Open Access | Times Cited: 2
Efficacy, immunogenicity, and safety of a monovalent mRNA vaccine, ABO1020, in adults: A randomized, double-blind, placebo-controlled, phase 3 trial
Suad Hannawi, Xiaohong Wu, Ralph Elvi Villalobos, et al.
Med (2024) Vol. 5, Iss. 10, pp. 1282-1292.e3
Open Access | Times Cited: 2
Multivalent mRNA Vaccine Elicits Broad Protection against SARS-CoV-2 Variants of Concern
Monika Kumari, Kang-Hao Liang, Shih-Chieh Su, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 714-714
Open Access | Times Cited: 2
Development and Evaluation of Vaccination Strategies for Addressing the Continuous Evolution SARS-CoV-2 Based on Recombinant Trimeric Protein Technology: Potential for Cross-neutralizing Activity and Broad Coronavirus Response
Peng Du, Ning Li, Shengjun Tang, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34492-e34492
Open Access | Times Cited: 1
Immunogenicity and protection efficacy of self-amplifying and circular mRNA vaccines for SARS-CoV-2
Oinam Ningthemmani Singh, Umang Berry, Garima Joshi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice
Charlie Fricke, Lorenz Ulrich, Jana Kochmann, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 4, pp. 102360-102360
Open Access | Times Cited: 1
Animal models for COVID-19 and tuberculosis
Björn Corleis, Max Bastian, Donata Hoffmann, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
SARS‐CoV‐2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice
Charlie Fricke, Florian Pfaff, Lorenz Ulrich, et al.
European Journal of Immunology (2023) Vol. 53, Iss. 12
Open Access | Times Cited: 2
Efficacy, Immunogenicity and Safety of a Monovalent Omicron BA∙4/5 mRNA Vaccine (ABO1020) Given as Heterologous Booster in Adults: A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial
Suad Hannawi, Ralph Elvi Villalobos, Erlina Burhan, et al.
(2024)
Closed Access
Comparison of a SARS-CoV-2 mRNA booster immunization containing additional antigens to a spike-based mRNA vaccine against Omicron BA.5 infection in hACE2 mice
Jacklyn R. Hurst, Maedeh Naghibosadat, Patrick Budowski, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0314061-e0314061
Open Access
The discovery and development of mRNA vaccines for the prevention of SARS-CoV-2 infection
Vivian Weiwen Xue, Sze Chuen Cesar Wong, Bo Li, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 7, pp. 769-780
Closed Access | Times Cited: 1
Page 1

Scroll to top